Purpose of review Work in the past decade has revealed key functions of the evolutionary conserved transcription factors Forkhead box O (FOXO) in the maintenance of homeostatic hematopoiesis. Here the diverse array of FOXO functions in normal and diseased hematopoietic stem and progenitor cells is reviewed and the main findings in the past decade are highlighted. Future work should reveal FOXO-regulated networks whose alterations contribute to hematological disorders.
INTRODUCTION
Forkhead box Os (FOXOs) are evolutionary conserved transcription factors, targets of the PI3-kinase/Protein kinase B (AKT) signaling pathway and implicated in an array of fundamental biological processes [1, 2] . Mammalian FOXOs comprise FOXO1, FOXO3, FOXO4, and FOXO6. FOXO (and specifically FOXO3) are implicated in sustaining longevity including in humans partly, but not exclusively through the regulation of oxidative stress. Single nucleotide polymorphism of FOXO3 is associated with exceptional longevity in humans although the mechanism remains unknown; [3] ).
FOXO1 and FOXO3 are the main FOXOs in the hematopoietic system [4] . In addition to phosphorylation by AKT serine threonine protein kinase, FOXOs are regulated by many posttranslational modifications, including acetylation/deacetylation, methylation, ubiquitination, and redox modulation (reviewed in [5] ). FOXO have an evolutionary conserved function in the cellular adaptation to growth factors. Growth factor availability causes kinases like AKT to phosphorylate FOXO proteins resulting in their translocation from the nucleus to the cytosol and negative regulation. On the other hand stress including oxidative stress promotes translocation of FOXO factors to the nucleus [6] . FOXOs are positively regulated by additional kinases including Jun N-terminal kinase, MST (Hippo signaling pathway) and 5 0 AMP-activated protein kinase. AKT phosphorylation and negative regulation of FOXO has been extensively studied in a variety of cultured lines. However, it is becoming clear that in primary hematopoietic stem and progenitor cells the regulation of FOXO is more complex [4, [7] [8] [9] and both phosphorylation and acetylation/deacetylation are in play [4, 9] . One of the main consequences of FOXO phosphorylation and acetylation is the regulation of their subcellular localization which ultimately governs their transcriptional activity. In fact, the FOXO functional output is determined by the combined effect of all their posttranslational changes (Figs 1-3 ).
FOXO AND HEMATOPOIETIC STEM CELLS
FOXOs constitute one of the few families of transcription factors that are essential for the proper functioning and regulation of stem cells within multiple adult tissues [11] . These include hematopoietic, neural, and muscle stem cell pools [12 && ,13 -15] . In this review, we will focus on the role of FOXOs within the realm of hematopoietic stem cells (HSCs).
FOXOs are essential for the maintenance of HSC pool and activity [7, 13, 16] . Conditional deletion of FOXO1/3/4 or deletion of FOXO3 alone compromised HSC pool and the long-term repopulation capacity of HSC in mice [7,10 && ,13,16,17] . In addition, although FOXO1 and FOXO3 are the main FOXOs expressed in HSCs, the regulation of subcellular localization and activity of FOXO1 and FOXO3 is relatively distinct [4, 9] ; FOXO1 showing more cytosolic localization and FOXO3 being almost entirely localized to the nucleus in HSC with long-term repopulation ability [4, [7] [8] [9] . These results together suggest FOXO3 is the main active FOXO within HSCs. In addition to compromised HSC function, loss of FOXO3 leads to increased myeloproliferation, anemia, and immune deficiencies that are similar to albeit milder than defects observed in triple FOXO-deleted mice [7, 13, 16, [18] [19] [20] .
In HSC, one of the main -and highly evolutionary conserved functions -of FOXO3 is the transcriptional regulation of expression of antioxidant enzymes and the control of levels of reactive oxygen species (ROS) [7, contributing to sequester FOXO3 within the nucleus [24, 25] . Ataxia-telangiectasia-mutated (ATM) kinase is the major DNA damage response protein phosphorylating more than 700 protein substrates. FOXO3 has been shown to control both ATM activity and expression [7, 26] , although the exact mechanisms by which ATM deficiency contributes to the FOXO3-deficient HSC phenotype remains unknown. In summary, FOXOs are an integral part of the DNA damage response and repair in HSCs. It would be interesting to see if they also participate in pathways other than base excision repair.
ROS are produced mainly in mitochondria during oxidative phosphorylation. HSC are highly sensitive to ROS; unbalanced accumulation of ROS in HSC leads to defects in stem cell maintenance and increased differentiation (reviewed in [27] ]. These studies suggest that mitochondrial defects rather than increased ROS impair FOXO3 À/À long-term repopulation activity of HSC, although the direct FOXO3-regulated mitochondrial target remains unknown. In addition, these defects suggest that loss of FOXO3 creates an HSC in which the mitochondrial metabolism has a paradoxical profile relative to the HSC activity [10 && ]. The consequences of mitochondrial dysfuntion for in vivo evolution of FOXO3-deficient HSC remain unclear.
Autophagy functions as a homeostatic mechanism that mediates the consumption of damaged or old cellular components. Autophagy has been shown to be a source of energy for the maintenance of HSC homeostasis during starvation, stress, and aging [28 && ,29]. FOXO are major regulators of autophagy and many of autophagy-related genes are transcriptionally regulated by FOXOs [30, 31] . In this regard, FOXO3 was identified as the main factor regulating autophagy in HSC [32] . It remains to be seen whether defects in mitochondrial clearance via autophagy -that is known as mitophagy -[12 && ,33] in FOXO3-deficient HSC is involved in increased ROS and/or decreased long-term repopulation activity.
To exert its important biological functions, FOXO3 is well maintained in an active nuclear form in the HSC and responds only under certain circumstances to the negative AKT regulation to become slightly cytosolic [4, [7] [8] [9] 13] . Sirtuin 1 (SIRT1) -a deacetylase for histones and other proteins including FOXO3 -is key in maintaining FOXO3 in the HSC nucleus [4, 9] . As both FOXO3 and SIRT1 are implicated in protecting HSC from age-associated damage [9,10 && ,32,34] one might speculate that SIRT1 regulation of FOXO3 may be part of a protein network that protects HSC from aging (reviewed in [27] ). In addition to SIRT1, micro-RNA 212/132 cluster and FANCD2 are also implicated in maintaining FOXO3 in the HSC nucleus [24, 25, 34] .
FOXO AND MYELOID CELLS
FOXOs have also been shown to be key regulators of myeloid progenitor cell production [16, 19] . FOXO3-deficient HSCs show myeloproliferation because of ROS accumulation that mediated the activation of the AKT-mammalian target of rapamycin (mTOR) signaling pathway in hematopoietic progenitor cells [19] . SH2B adapter protein 3 also known as lymphocyte adaptor protein (LNK) is an adaptor protein implicated in cytokine receptor signaling with regulatory role in hematopoiesis, cell migration, and inflammation. LNK is a negative regulator of HSC [35] and loss of LNK expression also contributes to myeloproliferation in mice [36] . It was shown that FOXO3 À/À myeloproliferation was partly because of the ROS-mediated deregulated LNK expression resulting in the constitutive activation of AKTmTOR signaling pathway in myeloid progenitor cells [19] . Interestingly LNK mutations are observed in a subset of human myeloproliferative neoplasms.
FOXO AND IMMUNE T AND B CELLS
T and B cells express FOXO1 and FOXO3; FOXOs are critical for T-cell homeostasis (reviewed in [37] ). Homeostasis of T cells is an important cellular process defined by the immune system's ability to maintain normal T-cell counts and at the same time, replenish the T-cell counts following T-cell depletion or expansion [38] . Some of the key factors that regulate this process are the cytokines like interleukin 7 and through the interactions between T-cell antigen receptor and major histocompatibility complex.
Although FOXOs are shown to promote apoptosis in response to nutrient or cytokine withdrawal in lymphocytes, their exact role in T-cells remains complex. In this regard, Kerdiles et al. [39] showed that conditional deletion of FOXO1 alters T-cell homeostasis. FOXO1 was shown to be essential for the regulation of several genes involved in T-cell trafficking and survival. Further, they showed that FOXO1 is involved in the negative feedback regulation of growth factor signaling coupled with homing of naive T cells and their subsequent survival [39, 40] . Another study showed that the expression of a constitutively active FOXO1 mutant in Jurkat cells led to a transcriptional activation of genes involved in lymphocyte recruitment into secondary lymphoid organs [41] . FOXO1 deletion resulted in decreased expression of Sell, C-C chemokine receptor type 7, Endothelial Differentiation Gene 1 and Kruppel-like factor 2 [39, 40] . FOXO1 is also shown to be involved in T-cell tolerance [42] . FOXO1 deficient naive T cells showed a decrease in B-cell lymphoma 2 (Bcl-2) expression and interleukin-7R signaling, mainly because of FOXO1's transcriptional control of interleukin-7R expression. Subsequent interleukin-7R rescue experiments restored Bcl-2 expression.
Apart from T-cell homeostasis and tolerance, the role of FOXO1 in B cells -especially as an inducer of recombination-activating gene (Rag)1 and Rag2 recombinase expression -has been documented. In-vitro knockdown of FOXO1 hindered Rag1 and Rag2 expression mediated by GADD45. The potential mechanism remains to be determined [43, 44] .
FOXO1 is also shown to be critical for class switch recombination that mediates antibody diversity in B cells. Loss of FOXO1 led to decreased immunoglobulin heavy chain production concomitant with decreased expression of B-cell-specific activation-induced cytidine deaminase that initiates class switch recombination [44, 45] . These combined studies show the importance of FOXO1 in T and B-cell biology.
The role of FOXO3 in the immune system, unlike FOXO1, is quite diverse and widespread. FOXO3 has been shown to have a role in T and Bcell death. Interleukin-2 is a potent T-cell mitogen that contributes to T-cell survival via Phosphatidylinositide 3-kinase signaling. Interleukin-2 withdrawal results in G1 phase arrest and apoptosis. These processes are mediated by FOXO3 activation and mainly through transcriptional regulation of Cyclin-dependent kinase inhibitor 1B (p27), cyclin Gap 2 phase in cell cycle (G2), Gadd45a and Retinoblastoma-like protein 2 (RBL2), all normally inhibited by interleukin-2. In the absence of interleukin-2, FOXO3 interacts with p53 Upregulated Modulator of Apoptosis and Bim promoters to induce apoptosis [46] . Other FOXO3 target genes, like Glucocorticoid-induced Leucine Zipper (GILZ) which is induced after interleukin-2 withdrawal delays apoptosis. This in turn is because of inhibition of Bim and p27 expression by GILZ [47, 48] . FOXO3 activity has also been shown to be important for memory T-cell survival wherein the difference has been observed between central memory and effector memory T cells [49] . It has been shown that impaired T-cell survival in a mouse model of virus/bacterial infection was associated with FOXO3 upregulation. Similarly, Dejean et al. [50] showed that FOXO3 deficiency following viral infection increased the expansion of T-cell population because of the ability of FOXO3-deficient dendritic cells to produce increased amounts of interleukin-6 to support T-cell viability.
FOXO3 also hinders the proliferation and survival of B cells via B-cell receptor interaction. Expression of AKT independent variants of FOXO3 induced partial G1 arrest in mouse primary B cells via induction of cyclin G2 and Retinoblastoma-like protein 1 genes that play crucial roles in B-cell quiescence [51] .
FOXO IN THE GENERATION OF RED BLOOD CELLS (ERYTHROPOIESIS)
Erythropoiesis is defined as the multistep complex process of red blood cell (RBC) production via differentiation and lineage restriction of HSCs. It begins with the generation of multipotent progenitor cells which then generate the lineage-committed progenitors burst-forming unit erythroid cells, differentiating into the colony-forming unit erythroid cells (CFU-Es). During terminal maturation, although erythroblasts accumulate hemoglobin, they reduce cell size and condense their nuclei. After enucleation, reticulocytes remodel their membrane and clear mitochondria and remaining organelles to generate fully mature erythrocytes. These processes are mainly regulated by the signaling from the erythropoietin receptor and erythroid lineage-specific transcription factors including GATA binding protein 1 (GATA-1), KLF-1, T-cell acute lymphocytic leukemia protein 1, and their cofactors [52, 53] . As erythropoiesis proceeds, increased accumulation of hemoglobin in erythroid cells leads to the generation of ROS. To prevent oxidative damage within RBC precursors, the expression of antioxidant enzymes increase as well with terminal erythroid maturation. Defects during any of these steps may lead to blood disorders, decrease in oxygen transporting capacity or insufficient RBC production and anemias.
In maturing erythroid cells, FOXO3 is the main active FOXO [18] . FOXO3 is regulated by erythropoietin receptor signaling in cultured erythroid lines [54, 55] . FOXO3 physiological function in erythroid cells was initially suspected based on the anemia in FOXO3 À/À mice. FOXO3 also showed increased expression, transcriptional activity and nuclear localization during both mouse and human erythroid cell maturation [18, 56] . It was subsequently shown that FOXO3-deficient erythrocytes exhibit increased levels of ROS associated with decreased levels of ROS scavenging enzymes which leads to ROS-mediated reduced RBC lifespan [18] that leads to the (compensated) anemia in FOXO3 À/À mice. In addition, absence of FOXO3 halted mitotic progression, contributing toward decreased erythroid maturation. Importantly, FOXO3-deficient mice died rapidly -as compared to Wild-Type mice -in response to induced oxidative stress underlying the importance of FOXO3 in regulating redox state during erythropoiesis [18] .
The microRNAs (miR) 144 and 451 are highly activated during erythroid maturation [57] [58] [59] . It was seen that miR-451 protects erythroid cells from oxidative stress [60] . The mechanism by which this occurs was shown to be via direct targeting of Ywhaz mRNA encoding 14-3-3z, by miR-451 (Also shown in [61] ). Abnormal accumulation of 14-3-3z following loss of miR-451 inhibited the activity of FOXO3 by translocating it from the nucleus to the cytoplasm. This ultimately impaired the expression of different FOXO3 regulated genes, including antioxidant enzymes required for maintaining the redox state [60] . During erythroid maturation, FOXO3 is induced by GATA-1; GATA-1 induction of FOXO3 is critical for the regulation of autophagy during terminal erythroid cell maturation [62, 63] .
Additional studies using integrated systems and experimental biology approaches identified FOXO3 as a critical factor involved at various stages of terminal erythroid maturation, especially for the correct temporal expression of genes expressed in maturing erythroblasts [33] . Loss of FOXO3 led to a defective terminal erythroid maturation and RBC production. FOXO3 was shown to be key for optimum RBC enucleation and key for mitochondrial clearance by autophagy [33] . Confocal microscopy analysis further suggested that loss of FOXO3 compromises the direction of the polarizing nucleus during expulsion. Ectopic expression of FOXO3 rescued the erythroid maturation and enucleation phenotype in FOXO3 null erythroblasts [33] . Mechanistically, FOXO3 forms a complex with signal transducer and activator of transcription 5 (STAT5), another factor that promotes erythroid survival and differentiation, and these together regulate Cited2 expression, a transcriptional coactivator, downstream of EPO and STAT5 and expressed in primitive erythroblasts [64, 65] .
FOXO3 is implicated in chronic erythroid disorders, including b-thalassemia and sickle cell disease [66,67,68 & ,69] . Importantly, expression of the FOXO3 stress-response program-related genes may determine the therapeutic response in b-thalassemia [69] . b-thalassemia is an inherited blood cell disorder characterized by ineffective erythropoiesis, oxidative damage, and anemia [70] . Interestingly, it was seen that resveratrol, a polyphenolic-stilbene, enhanced erythroid cell maturation, decreased red cell membrane oxidative damage and anemia in bthalassemic mice. Specifically, resveratrol upregulated the expression of antioxidant enyzmes including catalase and peroxiredoxin-2 via activation of FOXO3 which was mediated through AKT inhibition [66] . Despite these findings [69, 70] , the exact contribution of FOXO3 to b-thalassemia requires further investigations.
Taken together, these findings indicate that FOXO3 exert key functions at various stages of erythropoiesis and in distinct erythroid biological processes. Future work should elucidate mechanisms whereby FOXO3 connects signaling pathways and fundamental biological processes during terminal erythroid maturation.
FOXO AND HEMATOLOGICAL MALIGNANCIES
FOXO proteins were initially identified in human tumors as a part of chromosomal translocation breakpoints. Specifically, their involvement in malignancy was observed from the detection of fusion genes such as FOXO3-Mixed Lineage Leukemia (MLL), FOXO4-MLL, and FOXO1-Paired box (Pax) proteins 3 and 7 in alevolar rhabdomyosarcoma and acute myeloid leukemias [71] [72] [73] [74] [75] . The role of FOXO proteins as tumor suppressors stemmed from numerous studies including conditional triple deletion of FOXO1, FOXO3 and FOXO4 inducing spontaneous tumors including thymic lymphomas and hemangiomas in mice [76] characterized by increased proliferation and decreased apoptosis. Deletion of FOXO1, 3, and 4 or FOXO3 alone resulted in a myeloproliferative-like condition that in humans may precede leukemia [16, 19] . However, overall the phenotype of these tumors is relatively mild questioning the validity of the hypothesis that FOXOs function as tumor suppressors [77] . Additional data suggest that the function of FOXO proteins in cancer may be context dependent. This stems from the fact that leukemic stem cells capable of producing leukemic therapy-resistant cells require FOXO1, 3, 4 or at least FOXO3 to thrive including in humans [78] [79] [80] .
FOXO1 has also been implicated in the maintenance of leukemia-initiating cells via acting on bone marrow osteoblasts. HSC fate has been shown to be influenced by osteoblasts (or the bone-forming cells) [81, 82] . Osteoblasts are also known to regulate chronic versus acute myeloid leukemia progression [83] . Specifically, constitutive activation of b-catenin signaling in osteoblasts leads to Acute Myeloid Leukemia (AML) development [84] . FOXO1 has been shown to promote AML through its activating interaction with b-catenin in osteoblasts, and induction of Notch ligand Jagged- [87] ). The transcriptional activity of FOXO3A is required for prevention of myelogenous leukemia and B-chronic lymphocytic leukemia [88] . Alterations in FOXO functions are implicated in the abnormal activation of many signaling pathways [89] . In addition, a reverse-phase protein array study found that AML patients with high levels of phosphorylated FOXO3A had increased incidences of resistance to AML drugs and reduced durations of remissions [90] .
The role of FOXO proteins especially FOXO1 in lymphoma has been well documented. Diffuse large B-cell lymphoma (DLBCL), a form of B-cell nonHodgkin lymphoma is an aggressive cancer characterized by somatic driver mutations. One of the factors affected is FOXO1 [91, 92] . Although modulation of FOXO activity is often observed in malignancies, mutated FOXO in blood malignancies are extremely rare; mutations in DLBCL are however exceptions. Mutations within the FOXO N-terminal region reduced AKT phosphorylation at the Threonine 24 residue and subsequent loss of complex formation with 14-3-3 protein and increased nuclear retention and were associated with overall decreased survival. In a similar recent study [93] , FOXO1 ablation was shown to increase the therapeutic efficacy of rituximab, the only targeted therapy within the Rituximab, Cyclophosphamide, Doxorubicin, Vincristine (oncovin earlier), Prednisolone regimen administered to DLBCL patients. On the other hand, ablation of FOXO3 promoted myelocytomatosis virus oncoprotein-driven myeloid malignancy in a Vav protooncogene-MYC10 transgenic mouse model and Blymphomagenesis in an Em-myc transgenic mouse model [94] . Similarly, FOXO3 was found to be constitutively inactivated in a panel of mantel cell lymphoma cell lines, the reactivation of which led to cell cycle arrest and apoptosis [95] . Although clearly FOXOs are involved in many blood malignancies, their functions remain highly debated [77,96 & ].
CONCLUSION
It has become clear in the past decade that transcription factors FOXO are key regulators of homeostatic hematopoiesis implicated in many fundamental processes. Future studies may reveal conditions under which deregulated FOXO functions lead to hematological disorders. These studies may particularly illuminate FOXO's influence on heme malignancies.
Studies that identify FOXO-regulated programs that protect HSC from age-associated damage may provide important information related to age-associated FOXO alterations that would lead to blood disorders of the old. Using comet assays and g-H2AX analysis, this study shows that FOXO3 is an important DNA damage response protein in HSCs. It shows that loss of FOXO3 leads to accumulation of DNA damage. It also shows that FOXO3 contributes to oxidative DNA damage repair specifically to base excision repair. These results further support the possibility that FOXO3 protects HSC from age-associated damage.
